PHI 12/22 Private Health Insurance Legislation Amendment Rules (No. 2) 2022

Private health insurance clinical category and procedure type supplementary updates following additional Medicare Benefits Schedule (MBS) item changes from 1 March 2022

Date published:
PHI circular type:
PHI announcement
Audience:
Health sector

The Private Health Insurance Legislation Amendment Rules (No. 2) 2022 (the Amendment Rules No. 2) make consequential changes to the Private Health Insurance Rules to reflect the introduction of two new MBS items to treat chronic graft versus host disease (cGVHD) with integrated, closed-system, extracorporeal photopheresis (ECP) in conjunction with the drug methoxalen (on the Pharmaceutical Benefits Scheme), commencing 1 March 2022.

These Amendment Rules are in addition to the Private Health Insurance Legislation Amendment Rules (No. 1) 2022 which covered changes including pain management, anaesthesia, gynaecological and Participating Midwives services as well as amendments to the General Medical Services Table that made consequential changes to the Private Health Insurance Rules to reflect other changes to the MBS commencing 1 March 2022.

Further information on changes to the MBS for 1 March 2022, including fact sheets and quick reference guides is available at MBS Online.

The Amendment Rules No. 2 were registered on the Federal Register of Legislation commence on 1 March 2022.

The Amendments add items 13761, and 13762 to:

Further details on the Amendment Rules are included in the Explanatory Statement accompanying the Amendment Rules available on the Federal Register of Legislation or by searching ‘Private Health Insurance Legislation Amendment Rules (No. 2) 2022’.

Information and spreadsheets for MBS items assigned to a clinical category or procedure type are available at Private health insurance clinical category and procedure type.

Information on MBS item changes can be found at MBS Online.